Internal Medicine, Infectious Disease · Portland, OR
NPI
1811160468
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3181 SW Sam Jackson Park Road, Mail Code L-475
Portland, OR, 97239
Phone (503) 494-1198
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,288
81 services
Medicare patients, 2024
46
Average age 67
Drug cost, 2024
$3.8M
3,478 prescriptions
Company payments, 2025
$66.3
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher D Evans was code 99222 (hospital e&m - initial), 13 times for 13 patients. In total Christopher D Evans billed 81 services in 12 codes, and Medicare paid $5,288.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $104.60 | $1,360 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 13 | 12 | $13.82 | $180 |
| 99214 Office E&M - Established | Facility | 12 | 12 | $67.74 | $813 |
By year: 2022 $4,896 for 66 services; 2023 $5,483 for 78 services; 2024 $5,288 for 81 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher D Evans prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 332 prescriptions and refills. In total Christopher D Evans wrote 3,478 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 332 | 349 | 43 | $1.4M |
| Atorvastatin Calcium Generic | 303 | 422 | 43 | $2,039 |
| Tivicay Dolutegravir Sodium | 143 | 167 | 19 | $428K |
| Losartan Potassium Generic | 105 | 163 | 17 | $910 |
| Descovy Emtricitabine/Tenofov Alafenam | 102 | 122 | 11 | $253K |
| Prezcobix Darunavir/Cobicistat | 85 | 87 | Under 11 | $218K |
| Lisinopril Generic | 82 | 110 | 14 | $484 |
| Omeprazole Generic | 77 | 122 | 14 | $699 |
| Amlodipine Besylate Generic | 71 | 104 | 12 | $350 |
| Metoprolol Succinate Generic | 70 | 110 | Under 11 | $704 |
| Tamsulosin Hcl Generic | 67 | 97 | 12 | $576 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 60 | 60 | Under 11 | $223K |
| Gabapentin Generic | 57 | 93 | 14 | $1,393 |
| Acyclovir Generic | 54 | 96 | Under 11 | $857 |
| Trazodone Hcl Generic | 53 | 57 | Under 11 | $224 |
Brand drugs: - claims; generic drugs: 2,350 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher D Evans $66.3 ($66.3 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $66.3.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $66.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.